← Back to headlines
Teva and Sanofi Report Positive Phase 2b Results for Ulcerative Colitis and Crohn's Disease Drug
Teva and Sanofi announced durable phase 2b efficacy results for their drug duvakitug, intended for the treatment of ulcerative colitis and Crohn's disease.
17 Feb, 11:15 — 17 Feb, 11:15
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
‘I tested a patient’s urine and it showed sugar. After that, I tested blood sugar and it was 85 mg/dL, which is normal. What is the reason for this?’
11m ago
Ten thousand steps? Intensity and strength are more important
11m ago
Addiction expert on smartphone detox in schools: "A fifth experienced withdrawal symptoms"
11m ago
Prevention is the cheapest health reform, but we keep postponing it
11m ago